Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03122717 |
|---|---|
| Brief Title: | Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer |
| First Submitted : | April 4, 2017 |
| First Submitted that Met QC Criteria : | April 18, 2017 |
| First Posted : | April 21, 2017 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 14, 2024 |